Teniposide Injection bulk supplier for pharma manufacturers

Teniposide Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 50 mg/5 mL (10 mg/mL) ampoule

Reference Brands: Vumon (US/EU)

Teniposide injection (50 mg/5 ml) is a podophyllotoxin chemotherapy used mainly for childhood acute lymphoblastic leukaemia and some brain tumours. It is given by slow infusion because it can cause severe allergic reactions. The original brand Vumon has been discontinued in several countries, so supply is limited and we confirm current sources before quoting. Ask PharmaTradz for a quote; we confirm the manufacturer, registration documents and lead time for your country.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Teniposide Injection? List it or send an offer →

Product Description: Teniposide Injection (Vumon) is a chemotherapy drug used in the treatment of acute lymphoblastic leukemia (ALL) and neuroblastoma. Available in the U.S. and EU, Teniposide is typically supplied as 50 mg/10 mL (5 mg/mL) for intravenous infusion. As a topoisomerase II inhibitor, it interferes with DNA replication in cancer cells, preventing their division. This injectable formulation is essential in multi-drug chemotherapy regimens and is administered under the supervision of healthcare professionals in clinical settings. It requires careful handling due to potential side effects, including bone marrow suppression and liver toxicity, making it suitable for B2B pharmaceutical distribution in oncology.

Teniposide Injection — third party manufacturing & bulk supply

Teniposide Injection is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Teniposide Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Teniposide Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Teniposide Injection →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing